Collective Accuryn Physiologic Signals and Signatures (CAPSS)

Potrero Medical

Status: Withdrawn

Conditions: Acute Kidney Injury; Abdominal Compartment Syndrome; Critical Illness; Septic Shock; Sepsis

Treatments: Device: Accuryn Monitoring System

Study type: Observational

Funder types: Industry

Identifiers

NCT03817281

CRD-06-100473

Details and patient eligibility

About

The CAPSS Study is a retrospective and prospective, multi-center, single-arm post-market data collection study with an FDA cleared device. Physiologic data measurements will be collected from enrolled subjects using electronic health records and data streams via the Accuryn Monitoring System. Analysis of these data has the potential to be able to acutely guide resuscitation and monitor trends for emerging critical conditions.

Full description

The primary objective of the CAPSS Study is to track and analyze changes in physiologic data streams to identify clinical signatures that may enable earlier diagnosis of, and effective intervention in, critical conditions.

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

1. Received Accuryn Monitoring System during hospital stay.
2. Diagnosed with or developed one or more of the targeted conditions while connected to the Accuryn Monitoring System.

Exclusion criteria

1. In the opinion of the investigator, the patient is unsuitable for the study.

Trial design

0 participants in 1 patient group

Accuryn Monitoring System

Description:

Observational only (no intervention). Study Cohort is patients using the Accuryn Monitoring System as a standard-of-care digital urimeter, during their standard course of treatment.

Treatment:

Device: Accuryn Monitoring System